We are live on ! Find out more
IHI icon

iShares US Medical Devices ETF

525 hedge funds and large institutions have $1.69B invested in iShares US Medical Devices ETF in 2025 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 116 increasing their positions, 230 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more call options, than puts

Call options by funds: $13.4M | Put options by funds: $4.97M

1.64% less ownership

Funds ownership: 42.05%40.41% (-1.6%)

4% less funds holding

Funds holding: 546525 (-21)

13% less capital invested

Capital invested by funds: $1.94B → $1.69B (-$247M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

24% less first-time investments, than exits

New positions opened: 39 | Existing positions closed: 51

50% less repeat investments, than reductions

Existing positions increased: 116 | Existing positions reduced: 230

Holders
525
Holders Change
-21
Holders Change %
-3.85%
% of All Funds
6.89%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
39
Increased
116
Reduced
230
Closed
51
Calls
$13.4M
Puts
$4.97M
Net Calls
+$8.45M
Net Calls Change
+$707K
Name Holding Trade Value Shares
Change
Change in
Stake
YDMI
226
Y.D. More Investments
Israel
$592K -$24.5K -400 -4%
ATPW
227
Ashton Thomas Private Wealth
Arizona
$578K -$50.8K -830 -8%
BNP Paribas Financial Markets
228
BNP Paribas Financial Markets
France
$575K -$8.93M -145,972 -94%
FI
229
Finivi Inc
Massachusetts
$564K +$11.3K +184 +2%
FFA
230
First Foundation Advisors
California
$558K
SCM
231
Sage Capital Management
New Jersey
$552K +$489 +8 +0.1%
WW
232
Westshore Wealth
California
$546K
Renaissance Technologies
233
Renaissance Technologies
New York
$535K +$544K +8,900 New
MSFS
234
Main Street Financial Solutions
Pennsylvania
$532K -$25.7K -420 -5%
PAS
235
Park Avenue Securities
New York
$532K -$12.7K -207 -2%
SWA
236
Sax Wealth Advisors
New Jersey
$531K +$47K +769 +10%
KA
237
Kovack Advisors
Florida
$517K -$139K -2,279 -21%
CB
238
Commerce Bank
Missouri
$514K -$49.5K -810 -9%
RWMH
239
Riverpoint Wealth Management Holdings
Illinois
$510K +$551 +9 +0.1%
CT
240
Caldwell Trust
Florida
$507K -$9.18K -150 -2%
Koshinski Asset Management
241
Koshinski Asset Management
Illinois
$506K -$11K -180 -2%
WCWM
242
Willow Creek Wealth Management
California
$505K +$514K +8,407 New
WAM
243
Weiss Asset Management
Massachusetts
$500K +$509K +8,322 New
DADC
244
D.A. Davidson & Co
Montana
$500K -$165K -2,703 -25%
BCV
245
Banque Cantonale Vaudoise
Switzerland
$491K -$1.47M -24,000 -75%
OWM
246
Opes Wealth Management
California
$490K
MWM
247
Modern Wealth Management
Kansas
$484K -$2.13M -34,854 -81%
NL
248
NWAM LLC
Washington
$483K -$195K -3,184 -29%
M&T Bank
249
M&T Bank
New York
$482K
BW
250
Balance Wealth
Ohio
$476K -$123K -2,011 -20%

IHI Hedge Fund Activity: Q3 2025 in Review

525 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in iShares US Medical Devices ETF (IHI) for Q3 2025, worth a combined $1.69B — down 13% from $1.94B a quarter earlier.

Sellers outnumbered buyers: 51 funds closed out of IHI and 39 opened new positions — a net loss of 12 holders — while 230 trimmed existing stakes and 116 added.

The largest buyer was Nan Shan Life Insurance, adding an estimated $13.7M. The largest seller was Menora Mivtachim Holdings, cutting an estimated $56.2M.

  • 525 institutional investors held iShares US Medical Devices ETF (IHI) as of Q3 2025, down from 546 in Q2 2025.
  • Funds reported $1.69B of iShares US Medical Devices ETF stock for Q3 2025, down 13% quarter-over-quarter.
  • 39 funds opened new iShares US Medical Devices ETF positions in Q3 2025 and 51 closed out, a net change of -12 holders.
  • The largest iShares US Medical Devices ETF buyer in Q3 2025 was Nan Shan Life Insurance, an estimated $13.7M added.
  • The largest iShares US Medical Devices ETF seller in Q3 2025 was Menora Mivtachim Holdings, an estimated $56.2M sold.

Based on aggregated 13F filings for Q3 2025.